Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura A Boos

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Glia|September 25, 2004
Murine complement C4 is not required for experimental autoimmune encephalomyelitisLaura A Boos, Alexander J Szalai, Scott R Barnum
Histopathology|June 7, 2013
Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 casesLaura A Boos, Matthias Dettmer, Anja Schmitt, et al.
Cancers|June 28, 2019
MiRNAs Are Involved in Tall Cell Morphology in Papillary Thyroid CarcinomaLaura A Boos, Anja Schmitt, Holger Moch, et al.
Cancers|August 14, 2025
Precision Oncology Guided by Genomic Profiling in Breast Cancer: Real-World Data from a Molecular Tumor BoardTim Graf, Laura A Boos, Tarun Mehra, et al.
JTO Clinical and Research Reports|December 3, 2024
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line TreatmentSabine Schmid, Lisa Holer, Katrin Gysel, et al.
Scientific Reports|March 6, 2023
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancerChristoph Mamot, Andreas Wicki, Ursula Hasler-Strub, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Glia|September 25, 2004
Murine complement C4 is not required for experimental autoimmune encephalomyelitisLaura A Boos, Alexander J Szalai, Scott R Barnum
Histopathology|June 7, 2013
Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 casesLaura A Boos, Matthias Dettmer, Anja Schmitt, et al.
Cancers|June 28, 2019
MiRNAs Are Involved in Tall Cell Morphology in Papillary Thyroid CarcinomaLaura A Boos, Anja Schmitt, Holger Moch, et al.
Cancers|August 14, 2025
Precision Oncology Guided by Genomic Profiling in Breast Cancer: Real-World Data from a Molecular Tumor BoardTim Graf, Laura A Boos, Tarun Mehra, et al.
JTO Clinical and Research Reports|December 3, 2024
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line TreatmentSabine Schmid, Lisa Holer, Katrin Gysel, et al.
Scientific Reports|March 6, 2023
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancerChristoph Mamot, Andreas Wicki, Ursula Hasler-Strub, et al.
Pageof 1